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Risk factorsWe would like to respond to the letter sent by Dr.
Bell and Dr. Sander on 6th March.
Firstly, the establishment of survivor status for all
attendees of the tertiary referral centre for epilepsy
is questioned. Through the electronical patient
record system, which is continually updated, we
obtained an exact number of deaths in our patient
population. Consequently, there is no reason to
believe an underestimation of death rates has
occurred. The number of patient years was derived
from the number of patients attending the epilepsy
centre during the period under study. Again, the
electronical patient record system provided reliable
numbers of attending patients. A mean number of
4400 people with epilepsy were treated per year.
The majority of this population is receiving chronic
treatment for their epilepsies. Another part of the
population stays under the attention of the epilepsy
centre for a shorter period, but there is a steady
turnover of these patients which is illustrated in the
mean number of attending patients.
The study period comprised 5.3 years resulting in
23,230 patient years. With 29 definite and probable
SUDEP cases, the SUDEP rate of 1.24 per 1000
patient years was calculated. If we would have
included only definite SUDEP cases, the SUDEP rate
would have been even lower, that is 0.21 per 1000
patient years, but we believe this would be an
actual underestimation of SUDEP. If we would have
obtained exact patient years of follow up, perhaps
we would have obtained a slightly lower number of1059-1311/$ — see front matter # 2007 British Epilepsy Association
doi:10.1016/j.seizure.2007.06.007patient years resulting in a somewhat higher SUDEP
rate, but almost certainly not in excess of 1.5 per
1000 patient years.
The choice for the non-SUDEP deaths as controls
can be justified in different ways. The aim of the
study was to identify risk factors for SUDEP in an
alreadyhigh-riskpopulation.Hence,patients attend-
ing a tertiary referral centre frequently suffer from
refractory epilepsy and, consequently, are on AED
polytherapy.With this study,wehoped to identify the
factors that possibly predict a patient with epilepsy
to be prone of SUDEP. Using the non-SUDEP deaths as
controls, a group of patientswith epilepsy is explored
that is comparable to the SUDEP group, with the
difference that they died due to other causes and
not SUDEP. Differences in individual or epilepsy char-
acteristics between those two groups, would show
the risk factors for SUDEP. Eventually, we were not
able to identify such risk factors.
We understand the obtained SUDEP rate is unex-
pectedly low and not comparable to the rates
achieved in countries such as the United Kingdom.
Possibly differences in the health system are one of
the factors contributing to this considerable differ-
ence in SUDEP rate.
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